☰
Prestige BioPharma (Prestige), a renowned Singapore-based biopharmaceutical company, has reportedly announced that it has signed two new agreements that would allow it to supply and commercialize its biosimilar trastuzumab, HD201, across Russia and parts of Europe.
Reports cite, the company signed the latest of the two deals with Pharmapark LLC, a private Russian pharmaceutical firm that is marketing five biosimilars across Russia at present. Meanwhile, the company inked the second deal with Mundipharma, a UK-based pharmaceutical company.
According to reports, the Mundipharma agreement would give the trastuzumab biosimilar access across a number of European countries including Spain, France, Sweden, Norway, Finland, Denmark, Austria, Switzerland and Portugal following the drug’s approval by the European Commission.
The CEO of Prestige BioPharma, Lisa S. Park, PhD, stated that the company is thrilled to collaborate with Mundipharma to commercialize its leading biosimilar across select European markets. Park further added that the proposed partnership is a crucial milestone for Prestige as it will boost the global availability of trastuzumab and benefit more patients through its accessibility and quality.
The new deals reportedly come as the latest in a string of agreements concerning the biosimilar for the Singapore-based biopharma company; in the fourth quarter of 2018, Prestige inked a licensing agreement with Cipla Limited to supply and commercialize trastuzumab across emerging markets. Earlier, the company also announced a deal with Alvogen to distribute the biosimilar across Eastern and Central Europe.
Sources familiar with the matter claim that the proposed biosimilar is currently being reviewed by the European Medicines Agency. Moreover, the company also plans to submit an application for the biosimilar with the U.S. FDA by the end of 2019.
Source Credits:
Meta, the leading American technology company and the owner of social media platforms Facebook and Instagram, has reportedly announced its plans to lay off around 10,000 employees. Apparently, this is going to be the second round of significant la...
Heathrow Airport, the U.K.’s leading international airport, has reportedly been advised to reduce passenger costs for airlines next year, as they would have an impact on ticket pricing. The Civil Aviation Authority (CAA) determined that lowe...
Amazon, the U.S.-based e-commerce giant, has reportedly inked a deal with struggling mortgage lender, Better.com to provide better perks to employees. For the unversed, Better.com is introducing Equity Unlocker, a product that enables staff member...
© 2024 IntelligenceJournal.com. All Rights Reserved.
